Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective

Werner Scherbaum, Gordon Goodall, Katrina Erny-Albrecht, Massimo Massi-Benedetti, Erland Erdmann, William Valentine

    Research output: Contribution to journalArticlepeer-review

    13 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1-12
    Number of pages12
    JournalCost Effectiveness and Resource Allocation
    Issue number9
    Publication statusPublished - 2009

    Cite this